Cel-Sci
CVM
#9766
Rank
โ‚น4.63 B
Marketcap
โ‚น579.44
Share price
2.54%
Change (1 day)
-54.37%
Change (1 year)

EPS for Cel-Sci (CVM)

EPS in 2025 (TTM): -โ‚น953.27

According to Cel-Sci 's latest financial reports the company's current EPS (TTM) is -โ‚น1,010. In 2024 the company made an earnings per share (EPS) of -โ‚น45.82 an increase over its 2023 EPS that were of -โ‚น65.58.

EPS history for Cel-Sci from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น953.271980.62%
2024-โ‚น45.82-30.14%
2023-โ‚น65.58-16.09%
2022-โ‚น78.16-3.33%
2021-โ‚น80.859.76%
2020-โ‚น73.6715.49%
2019-โ‚น63.78-62.03%
2018-โ‚น167.992.19%
2017-โ‚น164.40-22.78%
2016-โ‚น212.91-77.45%
2015-โ‚น944.18-13.14%
2014-โ‚น1,08761.33%
2013-โ‚น673.77-57.14%
2012-โ‚น1,572-45.31%
2011-โ‚น2,875-420%
2010โ‚น898.36-112.9%
2009-โ‚น6,962342.86%
2008-โ‚น1,572-30%
2007-โ‚น2,246-0%
2006-โ‚น2,246150%
2005-โ‚น898.36-0%
2004-โ‚น898.36-75%
2003-โ‚น3,593-54.29%
2002-โ‚น7,861-31.37%
2001-โ‚น11,45415.91%
2000-โ‚น9,882-15.38%
1999-โ‚น11,679-29.73%
1998-โ‚น16,620-26%
1997-โ‚น22,459-13.79%
1996-โ‚น26,053

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Curis
CRIS
-โ‚น329.70-67.35%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น4.49-99.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,171-215.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚น159.01-84.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น56.60-105.60%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
โ‚น937.84-192.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น126.67-112.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น6,891 582.47%๐Ÿ‡บ๐Ÿ‡ธ USA